Vomiting, diarrhea and pancreatitis in dogs: the cheap claim, the expensive one, and the flare that comes back

Where stomach claims rank, and what a ranking cannot tell you

The North American Pet Health Insurance Association publishes a list of the conditions its members pay claims for most often. The 2026 State of the Industry highlights, dated June 21, 2026 and covering calendar 2025, put GI at the top of the dog list. Two more digestive entries appear further down: diarrhea in eighth place and vomiting in twelfth, the last slot. For cats GI is also first and vomiting ninth, with no separate diarrhea entry. NAPHIA notes that its claims pages use member-contributed data only.

Source: NAPHIA State of the Industry Report 2026 highlights, page 28. The report gives the order only, with no counts or dollar amounts behind each rank.

Three entries for one organ system says something about how claims are coded. The same dog can appear under vomiting in March, when the clinic records a sign, and under GI or pancreatitis in April, once tests give the sign a name. That relabelling is harmless on a single claim. It matters on the third, because the condition name on the file is what a per-condition deductible, a per-incident limit or a related-condition exclusion attaches to.

The UK primary-care data adds the scale. O'Neill and colleagues worked from the records of 2,250,417 dogs seen in 2019 and estimated a one-year incidence risk for acute diarrhoea of 8.18 percent. Vomiting was recorded alongside the diarrhoea in 44.25 percent of cases, and 29.32 percent were recorded as haemorrhagic. Those are UK figures from general practice, not insurance claims, but they explain why the category tops an insurer's list: it is frequent, it starts young, and most of it is cheap.

From one visit to a pancreatitis stay: what each level bills

A stomach claim is easier to read as a ladder than as a single price. Most episodes stop on the bottom rung. A smaller share climbs to an overnight stay on fluids, and pancreatitis that needs hospital care sits at the top. Each rung adds lines to the invoice, and each brings a different clause into play.

The Merck Veterinary Manual's professional chapter on pancreatitis, reviewed in September 2025, describes what the top rung is built from. No single test should be used on its own; the manual calls the pancreatic lipase immunoreactivity assay the most specific test, and describes ultrasound as useful but operator-dependent. Fluid therapy is the mainstay for severe cases, with anti-nausea drugs such as maropitant or ondansetron, opioid pain relief and early feeding support. It also notes a newer drug, fuzapladib, that has conditional FDA approval for acute pancreatitis in dogs. On an invoice, each of those is its own line, and a claims reviewer sees them that way. This guide lists them as billing items only; what a dog needs is a decision for its veterinarian.

Two insurers publish figures for the upper rungs, and neither is a price. MetLife's owner page on pancreatitis, dated January 14, 2025 and written by a veterinarian the page says MetLife paid, describes one dog whose care cost "around $3,000" and who was "reimbursed nearly $2,600" on a policy with a $250 deductible and 90 percent reimbursement. The rounded numbers do not quite reconcile: $3,000 less $250, at 90 percent, is $2,475, and $2,600 back would need a bill of roughly $3,140. Read insurer anecdotes as illustrations, which is how MetLife labels this one.

Trupanion's actual-claims page, modified October 3, 2025, lists "Parvo gastroenteritis" treated with IV fluids and medication at $5,084 from a real member claim. It is the clearest published figure for a hospitalised digestive illness, and it carries a catch of its own. Parvovirus is vaccine-preventable, and the Figo sample refuses claims for illnesses that a veterinarian-recommended vaccine would have prevented, naming canine parvovirus; the AKC sample excludes illness arising from not following a veterinarian's advice, including illness for which a vaccine is available. A gap in the vaccination record can matter more to that claim than the deductible.

Vomiting with no name yet: claims filed before a diagnosis

Many stomach claims are filed on a sign, not a diagnosis. The record says vomiting or diarrhoea, the dog improves, and no test ever names a cause. The insurer pays or declines on what the record shows, and the word on the record becomes the condition the file is opened under. At the expensive end, unexplained illness is not a small category. NAPHIA's list of the largest dog claims paid in 2025 is led by a $66.6K claim for a three-year-old Bernese Mountain Dog coded "Undiagnosed Illness - Chronic", followed by a $60.1K claim coded "Undiagnosed Hepatopathy"; a $42.3K claim for a ten-year-old Cavalier King Charles Spaniel is coded "Undiagnosed Illness - Acute". None is labelled as digestive, but each shows that a claim can be large while its name is still open.

For an owner, the undiagnosed stage matters most at enrolment. A vomiting visit before the start date is a recorded sign, and most forms reach recorded signs, not just diagnoses. The Figo multi-state dog sample defines "Undiagnosed" as not having been identified by a veterinarian, counts undiagnosed conditions with the same clinical signs as a pre-existing condition, and then writes a rule aimed squarely at stomach trouble: a dog treated for undiagnosed vomiting or diarrhea before the waiting period ends must be free of conditions with the same clinical signs for twelve consecutive months before any of them may be covered again. Twelve months of no recorded vomiting is a long time for a dog that raids bins.

Other documents set different clocks, and some name stomach upsets as the kind of problem that can come back into cover.

Sample forms are single-state examples and FAQ pages change; the declarations page and the form issued in your state control.

The table is kind to a one-off upset and hard on pancreatitis. Merck defines chronic pancreatitis by irreversible changes in the pancreas, and a form that excludes chronic conditions from its cured route, as the Spot sample does, has no clock for a dog whose record already says chronic. The label on the first visit is therefore worth reading before enrolment, not after.

Filing during the undiagnosed stage is ordinary claim filing: the itemised invoice and the visit's clinical notes go in together, as the claim filing guide sets out. The extra step is the follow-up. If a later visit gives the signs a name, send that record too and ask the insurer to file the earlier claims under the same condition. Whether that helps or hurts depends on the deductible design, which is the subject of the figure further down.

Is the second flare the same condition?

Recurrence is not a rare event here. In a Swiss primary-care practice, Berset-Istratescu and colleagues followed 96 dogs after an acute diarrhoea visit: 37 (38.5 percent) relapsed, 21 within three months and 16 more between three months and a year, and eating non-food items was a risk factor for relapse (Veterinary Journal, 2014). It is a small single-clinic study, but it puts a number on what owners of bin-raiding dogs already know. Pancreatitis recurs too; Merck describes chronic pancreatitis as capable of acute flare-ups, and MetLife's owner page describes chronic cases as prone to recurring episodes.

So the question for every second claim is how the form joins it to the first. The four documents below join episodes in four different ways, and each way moves money in a different direction.

Short quotations from each sample form. The Trupanion form is an older edition and may not reflect current terms.

Linking also reaches beyond the stomach. Merck lists exocrine pancreatic insufficiency and diabetes mellitus among the possible results of chronic pancreatitis, and the 2026 owner survey of UK Miniature Schnauzers by Johnson-Pitt and colleagues found a reported pancreatitis diagnosis associated with higher odds of a diabetes diagnosis. Under AKC's incident wording, a diabetes claim that follows pancreatitis may be read as a secondary diagnosis inside the same incident and its limit. Under a related-condition exclusion, a pancreatitis record from before enrolment could carry a later diabetes claim out of cover with it. Neither result is written into the forms for this pair of diseases, which is why it is worth asking an insurer, in writing, how it would treat them; the dog diabetes insurance guide compares the diabetes wording itself.

For the definitions behind these clauses, the pre-existing conditions guide walks through how chart entries are read. A returning bladder stone raises the same joining question with a surgery attached, and the bladder stone guide runs it through three clause designs. A cat whose stomach record is later biopsied as something else raises it with a pathology report attached, and the cat IBD and chronic vomiting guide follows that case.

The food and probiotic lines

The VetCompass study recorded what UK vets actually did for acute diarrhoea. The two most common items were probiotics, in 59.62 percent of cases, and dietary management, in 43.98 percent; antibiotics followed at 38.20 percent and maropitant, an anti-nausea drug, at 24.03 percent. Those first two are exactly the lines that policy forms treat most differently. On a one-visit upset they can be a fair share of the invoice, and for a dog on a long-term fat-restricted diet after pancreatitis they become the largest recurring cost of the condition.

Sample forms are single-state examples; the Trupanion form is an older edition. Your declarations page and any endorsements control.

Two phrases in that table deserve a second look. Spot's exclusion of food used "beyond resolution of symptoms" for prevention describes, almost word for word, a low-fat diet continued for years after a pancreatitis episode has settled. Research on Miniature Schnauzers with high blood fats has studied exactly that kind of diet (Xenoulis and colleagues tested a commercial low-fat diet in the Journal of Veterinary Internal Medicine in 2020), and it is the cost owners of the breed most often carry for years. Under the Spot wording it is likely to be paid while the episode is active and excluded afterward. Trupanion's older form reaches a similar place by a different road, paying half the food cost for two months and then switching to a premium discount.

AKC's exception is narrow in the other direction. A prescription diet is paid only when it is the sole treatment of a covered condition, so a diet prescribed alongside medication would seem to fall outside it. If a diet is a large part of your dog's management, ask the insurer whether the diet is paid during an active episode, after it, and with or without other treatment, because the three answers differ even within one company's forms.

Schnauzers, Cockers and Yorkies: three breeds that reach these clauses early

Merck's chapter says Miniature Schnauzers are "dramatically overrepresented" among dogs with pancreatitis and reports increased prevalence in Yorkshire Terriers, Cocker Spaniels, Dachshunds, Poodles and sled dogs. Three of those breeds have profiles on this site, and each meets the clauses above from a different direction.

The Miniature Schnauzer arrives with a laboratory finding that can predate any illness. In a 2007 study of 192 healthy Miniature Schnauzers, Xenoulis and colleagues found serum triglycerides above the reference range in 63 dogs (32.8 percent), against 2 of 38 healthy dogs of other breeds (5.3 percent), with both prevalence and severity rising with age. In the 2026 UK owner survey, 7.6 percent of 2,910 Schnauzers were reported to have had pancreatitis. For insurance, the triglyceride result is the record to think about: a raised value on a pre-enrolment blood panel is a written finding, and the related-condition wording above decides whether a later pancreatitis claim is tied to it. The breed profile shows a published anchor of $47 per month from MoneyGeek's cost analysis, reviewed October 4, 2026, which is a research average and not a quote.

The Cocker Spaniel adds a naming problem. Merck notes that English Cocker Spaniels have been proposed to have a distinct autoimmune form of chronic pancreatitis, while this site's profile, like the American registries, describes the American Cocker. A claim history that says chronic pancreatitis in either type will meet the chronic-condition limits on cured routes. Its published anchor is $57 per month (MoneyGeek, reviewed October 4, 2026, not a quote).

The Yorkshire Terrier shows up in both halves of this guide. Merck lists it among pancreatitis breeds, and in the VetCompass diarrhoea study it carried 1.51 times the odds of acute diarrhoea compared with crossbred dogs. The same study found higher odds in the Maltese and Miniature Poodle (2.17 each), the Cavapoo (2.07), the German Shepherd (1.69) and the Cockapoo (1.36), and higher odds in dogs under 3 and over 9 than in dogs aged 4 to 5. For a Yorkie, frequent small claims early in life are the realistic pattern, which makes the deductible design the clause that matters most. Its published anchor is $41 per month (MoneyGeek, reviewed October 4, 2026, not a quote).

These are UK and US research populations, and none of the figures predicts what any one dog will do. They do show why a breed's stomach history tends to arrive inside the policy's early years, when the waiting periods and pre-enrolment records are still close enough to matter.

Repeat flares, priced under annual and per-condition deductibles

To see how the joining rules move money, run the same three episodes through three designs. The inputs are invented round numbers, not prices or quotes. A dog has a $500 deductible, 80 percent reimbursement and no limit reached. Flare 1, in month 2, is a one-visit upset billed at $400. Flare 2, in month 7, is a pancreatitis admission billed at $3,000. Flare 3, in month 15, after the policy renews, is a recurrence billed at $1,200. Total billed: $4,600.

Design A is an annual deductible, the type the Spot, AKC, MetLife, Embrace and Healthy Paws documents describe. Design B is a per-condition deductible of the kind in Trupanion's 2011 form, with the insurer filing all three flares under one digestive condition. Design C is the same per-condition deductible with the first upset filed as a separate condition from the pancreatitis. The deductible, reimbursement and limits decoder quotes the deductible definitions from five sample forms and charts the same annual-against-per-condition split over four years for two recurring conditions.

The gap between the best and worst design here is $400 over 15 months, about one deductible. That is the honest size of the difference for a dog with a few flares, and it grows with every policy year in which a recurrence lands. It is also why linking cuts both ways. Under a per-condition deductible, having every flare filed as one condition saves money; under a related-condition exclusion on a new policy, the same linking keeps every later flare out of cover. The insurer's filing of the first claim decides which side you are on.

Two smaller levers sit on top of the deductible. The MetLife sample cuts the deductible by $50 at each renewal with no paid claims and resets it once a claim is paid; the Figo sample offers the same mechanism as an option. On that wording, a $400 visit that only fills the deductible produces no payment, so it would not appear to end the reduction, but ask the insurer before relying on it. Figo also lets an owner choose a per-incident copay, charged per incident and per treating provider on top of the annual deductible, which falls hardest on a dog that has many small episodes.

To put your own policy's numbers through the same arithmetic, the claim payout simulator takes a bill, a deductible and a reimbursement rate. The emergency vet visit guide covers the deposit a hospital may ask for before the admission, which a reimbursement policy does not pay up front, and the help paying vet bills guide sets out what to try when that deposit is the problem.